Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Qt framework used for the development of Stellantis’ newly launched in-vehicle HMI

Qt has been selected to add 3D effects and enhance the human-machine interface across its portfolio of iconic European automotive brands.Espoo, Finland – 9[th] February 2022 – The Qt Company , the leading global provider of software technology, announces that Stellantis , the global automaker and provider of innovative mobility solutions works with Qt for the development of their current in-vehicle HMI systems across its portfolio of iconic European car brands. The project, which began in 2018, will see the Qt technology used for the

DanCann Pharma A/S has submitted application to the Danish Medicines Agency for EU-GMP-approval for Biotech Pharm1

COPENHAGEN, Denmark, 9 February 2022 – DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”), a Danish company powered by cannabinoids, hereby announce that the Company submitted its application for EU-GMP-approval to the Danish Medicines Agency.In April, DanCann Pharma pressed the start button in the Company’s first production facility, Biotech Pharm1 in Ansager. Now the Company is ready to be inspected from the Danish Medicines Agency in order to be approved according to EU-GMP standards. The approval is expected to be in place by the half year of 2022. Biotech Pharm1 is

Invitation to presentation of Embracer Group’s Q3 report

Embracer Group hereby invites you to a presentation in connection with the publication of the interim report for the third quarter, the period October-December 2021. The report will be published at 06.00 (CET) on February 17th and available as of this time at: www.embracer.comThe presentation will be held in English by CEO Lars Wingefors and CFO Johan Ekström, and afterwards a Q&A session will follow, led by analyst Oscar Erixon from Carnegie. Date:           February 17, 2022 Time:          09:00 CET Location:     Karlstad CCC, Tage Erlandergatan 8, Karlstad Online:

Mandatory notification of trade

On February 8, primary insiders in Atea ASA completed the following transactions. Robert Giori sold 83,400 shares and entered a contract to purchase 83,660 shares. Robert Giori sold 83,400 shares at an average price of 140.15.  On the same day, he exercised 100,000 stock options in the company at an average strike price of NOK 92.00.  Following withholding of income taxes, he acquired 83,660 shares in the company through the exercise of options.  The shares will be transferred on February 9. After the transactions, Robert Giori owns 126,587 shares together with close associates, and

Transactions in connection with share buy-back programme

On 4 March 2021, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). On 18 March 2021, the share buy-back programme was increased by DKK 15 million, thereby increasing the maximum aggregate purchase price of the shares to be bought back under the programme to DKK 115 million. The share buy-back

RhoVac plans for a fully guaranteed convertible loan rights issue, to finance activities following a successful clinical phase IIb study outcome

RhoVac AB (”RhoVac”) announces today, February 9, 2022, that the Board of Directors intends to decide on execution of a preferential rights issue of a convertible loan (“the Planned Offer”) of approx. 25 M SEK in March/April 2022. The Planned Offer is via written agreement fully guaranteed, free of charge, by RhoVac’s largest shareholder M2 Asset Management AB. The objective of the Planned Offer is to further ensure that the company, given positive primary outcome results of the study, has the proper financial strength to negotiate and conclude optimally on the clinical phase IIb study follow-

BioStock: Evaxion Biotech publishes EVX-01 data in scientific journal OncoImmunology

This past decade has seen the rise of immunotherapies for the treatment of cancer, in many ways revolutionising this enormous treatment field. Danish Evaxion Biotech aims at pushing this development even further with its AI-powered personalised approach. The company recently published results from an ongoing phase I/IIa clinical study with lead drug candidate EVX-01 in the open access, peer-reviewed clinical journal OncoImmunology.Read the full article at biostock.se:https://www.biostock.se/en/2022/02/evaxion-biotech-publishes-evx-01-data-in-scientific-journal-oncoimmunology/This is a

Notice of extraordinary general meeting in NeoDynamics AB

The shareholders of NeoDynamics AB (publ), reg. no. 559014-9117 (the “Company”) are hereby convened to the extraordinary general meeting on Friday 25 February 2022 at 09.00 at the Company’s premises at Lejonvägen 14, Lidingö. Information regarding Covid-19 The Company takes the current Covid-19 situation very seriously and therefore urges all shareholders to carefully consider whether a personal / physical presence at the meeting is necessary and to consider the alternative of attending the general meeting through a proxy instead. Shareholders with cold or flu-like symptoms, including

CLS and Skåne University Hospital enter a clinical trial agreement to evaluate MR-guided Laser Interstitial Thermal Therapy (LITT) for glioblastoma ablation

Clinical Laserthermia Systems AB (publ) (CLS), which develops advanced innovative products for high-precision image guided laser ablation, announces that it has entered into an agreement with Skåne University Hospital  to sponsor a clinical trial evaluating the safety and feasibility of magnetic resonance (MR) guided laser interstitial thermal therapy (MRgLITT) for ablation of glioblastoma lesions, using the CLS TRANBERG® Thermal Therapy System with Thermoguide™ Workstation. Approval for this trial has been obtained from the Swedish Medical

TF Bank: Monthly statistics January 2022

The total loan portfolio amounted to SEK 11,181 million at the end of January. Compared to January 2021, the loan portfolio has increased by 32 % in local currencies.  Month Jan-22 Jan-21 ChangeConsumer Lending   New lending, SEK million 411 320 28 %Ecommerce Solutions   Transaction volume*, SEK million 588 293 101 %Credit Cards   New lending, SEK million 256 126 103 % *The sum of all purchases that goes through TF Bank’s payment solutions All figures for January 2022 are preliminary. For

Cereno Scientific publishes year-end report for 2021 (1 January – 31 December)

The Board and Chief Executive Officer of Cereno Scientific AB here presents the year-end report for the year 2021. Summary of the year-end report, January – December 2021Cereno Scientific Group Full year (1 January – 31 December 2021) · Net Sales were SEK 0 (0) · Result after financial items was SEK -16,254,890 (-16,017,958) · Earnings per share was SEK -0.15 (-0.22) before dilution and SEK -0.11 (-0.21) after dilution · The equity/assets ratio was 94.1% (88.9%) · Cash and bank balance was SEK 89,634,757 (66,004,352) Fourth quarter (1 October – 31 December 2021)

SCA appoints new CFO

SCA has appointed Andreas Ewertz as its new CFO. Ewertz has worked at SCA since 2017, where he has been responsible for investor relations and served as head of business control for business areas Publication Paper and Pulp, respectively.Ewertz, who will become a member of SCA group management, will take up the position as CFO on May 1, 2022. Prior to his employment at SCA, Ewertz worked in a number of different roles at Handelsbanken Capital Markets. Ewertz, born in 1987, holds a Master’s degree in Industrial Engineering and Management from Linköping University. Ewertz replaces current

Nel ASA: Invitation to presentation of Q4 2021 results

(Oslo, 9 February 2022) Nel ASA will announce its fourth quarter 2021 report on Wednesday 16 February at 07:00 CET and will host a presentation at 08:00 CET. The presentation will be held at Hotel Continental, Oslo at 08:00 CET. The presenter will be Jon André Løkke, CEO. The presentation will be followed by Q&A based on submitted questions during the call. The presentation will be broadcasted live at www.nelhydrogen.com and can also be streamed at https://channel.royalcast.com/landingpage/hegnarmedia/20220216_5/. As Covid-19 restrictions are lifted in Oslo, physical participation is

Balco solves overcrowding with groundbreaking product

By combining its knowledge of the market and its focus on innovation, Balco Group has developed a new product that solves overcrowding in apartment buildings. The product goes by the name Balco® Living and is primarily developed for the renovation segment - a market where Balco sees great potential.Balco Living means that an insulated and openable glazing system is added to the outside of the property together with concrete slabs from Balco. After completion of construction, each apartment in the property has been given a heated, integrated new living space of approximately 20 square meters.

Ideagen strikes first deal of 2022 as acquisition and growth drive continues

LEADER in compliance software for regulated industries, Ideagen Plc, has today revealed its first acquisition of 2022, with the purchase of MailManager Limited.The acquisition is an indicator of Ideagen’s ongoing and rapid growth strategy and was completed for an upfront cash consideration of £26.4 million. MailManager, a London-headquartered email management provider, helps businesses manage emails more efficiently and significantly improve control, collaboration and compliance, which is complementary to Ideagen’s existing regulated collaboration suite. Its software is designed to

The Smart City Mobility Index

The study reveals the global cities that are leading the way in sustainable transportation and improving the lives of their citizens through mobility innovation. · Barcelona, Spain, is the world’s leading city for mobility innovation with a population of over 3 million people, followed by Berlin, Germany and London, UK. · Copenhagen, Denmark, ranks as the world’s best city for mobility innovation with a population of between 600,000 and 3 million people, followed by Dortmund, Germany, and Amsterdam, Netherlands. · Lund, Sweden, is the best ranking city for mobility innovation with

Etteplan and Stockholm Exergi to extend their cooperation within technical asset information

Etteplan, Press release, February 9, 2022 at 9.00 am EET Stockholm Exergi has awarded Etteplan an extension of an existing agreement to develop their technical asset information. Stockholm Exergi provides heating and cooling through its distribution network and supplies electricity to the Stockholm area, including more than 800,000 Stockholmers and around 400 locations – including hospitals, data centers, and other private and public sites. The scope of the agreement covers the full range of technical asset information management which includes developing processes, providing

Partinc Capital raises capital from external investors including J2L Holding

Swedish investment company Partinc Capital AB has executed a directed share issue, whose proceeds will be invested in SaaS companies in Sweden and the Netherlands. In addition to a number of existing shareholders, several new investors participated, including J2L Holding AB and Dutch Vastgoed Holding BV. In conjunction with the issue, J2L Holding CEO Johan Lindh has assumed a seat on the board of Partinc Capital.Partinc Capital is an investment company focused on business-to-business SaaS providers. Current holdings are comprised of three Swedish unlisted companies, Lynes Technologies,

Invitation to the presentation of John Mattson’s year-end report for 2021, on 23 February at 11:00 a.m. (CET)

Invitation by John Mattson to the teleconference and webcast on Wednesday 23 February at 10:00 a.m. (CET) being held in conjunction with the publication of the company’s year-end report for 2021 at 8:00 a.m. (CET) the same date.Investors, asset managers, equity analysts, the press and other stakeholders are invited to participate in the conference, where CEO Per Nilsson and CFO Maria Sidén will comment on the year-end report for 2021. No advance notice of attendance is required. Following the presentation, it will be possible to ask questions. The presentation starts at 11:00 a.m. (CET)

Year-end Report January-December 2021

Fourth quarter · Order intake amounted to SEK 1,234 (865) million, up 43 percent · Net sales increased 30 percent to SEK 1,295 (992) million. Based on constant exchange rates, net sales increased 27 percent · EBIT amounted to SEK 204 (214) million and EBIT margin was 16 (22) percent  · Earnings per share were SEK 1.82 (1.80) January-December · Order intake amounted to SEK 4,506 (3,687) million, up 22 percent · Net sales increased 19 percent to SEK 4,635 (3,882) million. Based on constant exchange rates, the increase was23 percent · EBIT amounted to SEK 1,049 (898)

Invitation – presentation of fourth-quarter results

KlaraBo will publish its interim report for the fourth quarter of 2021 at 8:00 a.m. (CET) on Wednesday, 16 February, and will hold a webcast presentation and teleconference at 11:00 a.m. (CET) the same day. KlaraBo’s CEO Andreas Morfiadakis and CFO Jenny Appenrodt will present the interim report and respond to questions. The presentation will be held in English. TeleconferenceTime: 11:00 a.m. (CET) on Wednesday, 16 February 2022To participate in the teleconference, call: +46 8 505 583 69 Webcast presentationLink to webcast: https://tv.streamfabriken.com/klarabo-q4-2021The

Reminder: Invitation to presentation of Orkla’s fourth quarter 2021 results, Thursday 10 February

Orkla will report its fourth quarter 2021 results on Thursday, 10 February 2022 at 7.00 a.m. CET.The quarterly report and the presentation material will be available at this time at: https://investors.orkla.com.The results will be presented in a webcast with President & CEO Jaan Ivar Semlitsch and CFO Harald Ullevoldsæter at 8.00 a.m. CET. As a consequence of the Corona situation, there will not be a physical presentation of the results.The presentation and subsequent Q&A session will be held in English and may be viewed live at https://investors.orkla.com (direct link: https://events.

Dividend Payment

9 February 2022 Gulf Keystone Petroleum Ltd. (LSE: GKP) ("Gulf Keystone", "GKP" or "the Company") Dividend Payment On announcing Gulf Keystone's Operational & Corporate Update on 24 January 2022, the Company declared an interim dividend of $50 million. The payment is equivalent to 23.394 US cents per Common Share of the Company. It has been converted into pounds sterling at a rate of $1:£0.73540 prevailing on 8 February 2022, and hence a dividend of 17.204p per Common Share will be paid on 25 February 2022 to those shareholders on the register of members of the Company as at

ABGSC – Q4 2021 Interim Report

Highlights: · Strong finish to a record-breaking year with Q4 revenues of NOK 803m (NOK 893m) · 2021 full-year revenues of NOK 2,911m, up 51% from NOK 1,926m last year · 2021 diluted EPS of NOK 1.39 (+78%) · Proposed cash dividend of NOK 1.00 per share · Solid and diversified pipeline heading into 2022 CEO comment: I am very pleased to report that we have recorded 2021 revenues of NOK 2.9bn (+51%), the highest full-year revenues in the history of the firm. Q4 2021 provided a fair representation of the year, with revenues amounting to NOK 803m, only moderately behind

There are no items matching the current filter
There are no more items matching the current filter
Back to top